Clinical Significance of the Genetic Landscape of Pancreatic Cancer and Implications for Identification of Potential Long-term Survivors

Cancer statistics, 2012

Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679 · see citing works

Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969 · see citing works

Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice

Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609 · see citing works

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502 · see citing works

Massive genomic rearrangement acquired in a single catastrophic event during cancer development

Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414 · see citing works

Hyperactive Ras in developmental disorders and cancer

Schubbert, S., Shannon, K., & Bollag, G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2109 · Cited by 1,583 · see citing works

The patterns and dynamics of genomic instability in metastatic pancreatic cancer

Campbell, P. J., Yachida, S., Mudie, L. J., Stephens, P. J., Pleasance, E. D., Stebbings, L. A., Morsberger, L. A., Latimer, C., McLaren, S., Lin, M.-L., et al. (2010) · Nature · doi:10.1038/nature09460 · Cited by 1,317 · see citing works

Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma

Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M. E. M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., & Kern, S. E. (1994) · Nature Genetics · doi:10.1038/ng0994-27 · Cited by 1,132 · see citing works

<i>DPC4</i> Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer

Iacobuzio-Donahue, C. A., Fu, B., Yachida, S., Luo, M., Abe, H., Henderson, C. M., Vilardell, F., Wang, Z., Keller, J. W., Banerjee, P., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.7188 · Cited by 1,081 · see citing works

Activated Kras and <i>Ink4a/Arf</i> deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma

Aguirre, A. J., Bardeesy, N., Sinha, M., Lopez, L., Tuveson, D. A., Horner, J., Redston, M. S., & DePinho, R. A. (2003) · Genes &amp; Development · doi:10.1101/gad.1158703 · Cited by 1,033 · cited 4× · see citing works

Progression model for pancreatic cancer.

Hruban, R. H., Goggins, M., Parsons, J., & Kern, S. E. (2000) · PubMed · Cited by 872 · see citing works

<i>Smad4</i> is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer

Bardeesy, N., Cheng, K.-H., Berger, J. H., Chu, G. C., Pahler, J., Olson, P., Hezel, A. F., Horner, J., Lauwers, G. Y., Hanahan, D., et al. (2006) · Genes &amp; Development · doi:10.1101/gad.1478706 · Cited by 674 · see citing works

Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas.

Schutte, M. E. M., Hruban, R. H., Geradts, J., Maynard, R. D., Hilgers, W., Rabindran, S. K., Moskaluk, C. A., Hahn, S. A., Schwarte‐Waldhoff, I., Schmiegel, W., et al. (1997) · PubMed · Cited by 659 · see citing works

Small Cell and Large Cell Neuroendocrine Carcinomas of the Pancreas are Genetically Similar and Distinct From Well-differentiated Pancreatic Neuroendocrine Tumors

Yachida, S., Vakiani, E., White, C. M., Zhong, Y., Saunders, T., Morgan, R., de Wilde, R. F., Maitra, A., Hicks, J. L., Marzo, A. M. D., et al. (2012) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182417d36 · Cited by 536 · see citing works

The p53 Gene in Breast Cancer: Prognostic Value of Complementary DNA Sequencing Versus Immunohistochemistry

Sjögren, S., Inganäs, M., Norberg, T., Lindgren, A., Nordgren, H., Holmberg, L., & Bergh, J. C. S. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.3-4.173 · Cited by 381 · see citing works

<i>SMAD4</i> Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer

Blackford, A., Serrano, O. K., Wolfgang, C. L., Parmigiani, G., Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Eshleman, J. R., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0227 · Cited by 371 · see citing works

Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression.

Wilentz, R. E., Geradts, J., Maynard, R. D., Offerhaus, G. J. A., Kang, M., Goggins, M., Yeo, C. J., Kern, S. E., & Hruban, R. H. (1998) · PubMed · Cited by 337 · see citing works

Untitled work

(2001) · PubMed · Cited by 309 · see citing works

Immunohistochemical Labeling for Dpc4 Mirrors Genetic Status in Pancreatic Adenocarcinomas

Wilentz, R. E., Su, G. H., Dai, J. L., Sparks, A. B., Argani, P., Sohn, T. A., Yeo, C. J., Kern, S. E., & Hruban, R. H. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64703-7 · Cited by 304 · see citing works

Molecular prognostic markers in pancreatic cancer: A systematic review

Garcea, G., Neal, C. P., Pattenden, C. J., Steward, W. P., & Berry, D. P. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.04.044 · Cited by 257 · see citing works

Personalizing Cancer Treatment in the Age of Global Genomic Analyses: PALB2 Gene Mutations and the Response to DNA Damaging Agents in Pancreatic Cancer

Villarroel, M. C., Rajeshkumar, N. V., Garrido‐Laguna, I., Jesus‐Acosta, A. D., Jones, S., Maitra, A., Hruban, R. H., Eshleman, J. R., Klein, A. P., Laheru, D. A., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0893 · Cited by 249 · see citing works

Recurrent KRAS codon 146 mutations in human colorectal cancer

Edkins, S., & O’Meara, S. (2006) · Cancer Biology &amp; Therapy · doi:10.4161/cbt.5.8.3251 · Cited by 229 · see citing works

Inactivation of Smad4 Accelerates KrasG12D-Mediated Pancreatic Neoplasia

Kojima, K., Vickers, S. M., Adsay, V. N., Jhala, N. C., Kim, H., Schoeb, T. R., Grizzle, W. E., & Klug, C. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4167 · Cited by 197 · see citing works

Management of Patients with Pancreatic Adenocarcinoma: National Trends in Patient Selection, Operative Management, and Use of Adjuvant Therapy

Mayo, S. C., Gilson, M. M., Herman, J. M., Cameron, J. L., Nathan, H., Edil, B. H., Choti, M. A., Schulick, R. D., Wolfgang, C. L., & Pawlik, T. M. (2011) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2011.09.022 · Cited by 176 · see citing works

<i>DPC4</i>/Smad4 Expression and Outcome in Pancreatic Ductal Adenocarcinoma

Biankin, A. V., Morey, A. L., Lee, C.-S., Kench, J. G., Biankin, S. A., Hook, H. C., Head, D. R., Hugh, T. B., Sutherland, R. L., & Henshall, S. M. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.12.063 · Cited by 163 · see citing works

Novel Somatic and Germline Mutations in Cancer Candidate Genes in Glioblastoma, Melanoma, and Pancreatic Carcinoma

Balakrishnan, A., Bleeker, F. E., Lamba, S., Rodolfo, M., Daniotti, M., Scarpa, A., van Tilborg, A. A., Leenstra, S., Zanon, C., & Bardelli, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0065 · Cited by 161 · see citing works

Genetic evolution of pancreatic cancer: lessons learnt from the pancreatic cancer genome sequencing project

Iacobuzio–Donahue, C. A. (2011) · Gut · doi:10.1136/gut.2010.236026 · Cited by 158 · see citing works

Immortalizing the complexity of cancer metastasis: Genetic features of lethal metastatic pancreatic cancer obtained from rapid autopsy

Embuscado, E. E., Laheru, D. A., Ricci, F., Yun, K. J., Witzel, S. D. B., Seigel, A., Flickinger, K., Hidalgo, M. M., Bova, G. S., & Iacobuzio–Donahue, C. A. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.5.1663 · Cited by 151 · see citing works

Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer

Smith, R. A., Tang, J. H., Smith, C. T., Neoptolemos, J. P., & Ghaneh, P. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.110 · Cited by 109 · see citing works

DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy

van de Vaart, P. J. M., Belderbos, J. S. A., de Jong, D., Sneeuw, K. C. A., Majoor, D. M., Bartelink, H. G. M. M., & Begg, A. C. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000320)89:2 · Cited by 102 · see citing works

Disruption of p16 and Activation of Kras in Pancreas Increase Ductal Adenocarcinoma Formation and Metastasis in vivo

Qiu, W., Sahin, F., Iacobuzio-Donahue, C. A., Garcia-Carracedo, D., Wang, W. M., Kuo, C.-Y., Chen, D., Arking, D. E., Lowy, A. M., Hruban, R. H., et al. (2011) · Oncotarget · doi:10.18632/oncotarget.357 · Cited by 99 · see citing works

Missense Mutations of MADH4

Iacobuzio–Donahue, C. A., Song, J., Parmiagiani, G., Yeo, C. J., Hruban, R. H., & Kern, S. E. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1121-3 · Cited by 93 · see citing works

Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancer.

Fogelman, D. R., Wolff, R. A., Kopetz, S., Javle, M. M., Bradley, C. R., Mok, I., Cabanillas, F., & Abbruzzese, J. L. (2011) · PubMed · Cited by 91 · see citing works

Association of p53 Gene Mutations with Short Survival in Pancreatic Adenocarcinoma

Nakamori, S., Yashima, K., Murakami, Y., Ishikawa, O., Ohigashi, H., Imaoka, S., Yaegashi, S., Konishi, Y., & Sekiya, T. (1995) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1995.tb03036.x · Cited by 73 · see citing works

Immunohistochemical p16INK4a Analysis of Archival Tumors with Deletion, Hypermethylation, or Mutation of the CDKN2/MTS1 Gene

Geradts, J., Hruban, R. H., Schutte, M. E. M., Kern, S. E., & Maynard, R. D. (2000) · Applied immunohistochemistry & molecular morphology · doi:10.1097/00129039-200003000-00011 · Cited by 56 · see citing works

Assessment of sensitivity and specificity of immunohistochemical staining of p53 in lung and head and neck cancers.

Melhem, M. F., Law, J. C., El-Ashmawy, L., Johnson, J. T., Landreneau, R. J., Srivastava, S., & Whiteside, T. L. (1995) · Europe PMC (PubMed Central) · Cited by 56 · see citing works

Mutation status of K-ras, p53 and allelic losses at 9p and 18q are not prognostic markers in patients with pancreatic cancer.

Šálek, C., Mináriková, P., Benešová, L., Nosek, V., Strnad, R., Zavoral, M., & Minárik, M. (2009) · PubMed · Cited by 33 · see citing works

Detection and localization of surgically resectable cancers with a multi-analyte blood test

Cohen, J. D., Li, L., Wang, Y., Thoburn, C., Afsari, B., Danilova, L., Douville, C., Javed, A. A., Wong, F., Mattox, A., et al. (2018) · Science · doi:10.1126/science.aar3247 · Cited by 2,783 · see citing works

Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression

Laklai, H., Miroshnikova, Y. A., Pickup, M. W., Collisson, E. A., Kim, G., Barrett, A., Hill, R. C., Lakins, J. N., Schlaepfer, D. D., Mouw, J. K., et al. (2016) · Nature Medicine · doi:10.1038/nm.4082 · Cited by 598 · see citing works

Pancreatic cancer biology and genetics from an evolutionary perspective

Makohon-Moore, A. P., & Iacobuzio–Donahue, C. A. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.66 · Cited by 430 · see citing works

Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer

Makohon-Moore, A. P., Zhang, M., Reiter, J. G., Bozic, I., Allen, B., Kundu, D., Chatterjee, K., Wong, F., Jiao, Y., Kohutek, Z. A., et al. (2017) · Nature Genetics · doi:10.1038/ng.3764 · Cited by 403 · see citing works

The molecular biology of pancreatic adenocarcinoma: Translational challenges and clinical perspectives

Wang, S., Zheng, Y., Yang, F., Zhu, L., Zhu, X.-Q., Wang, Z.-F., Wu, X.-L., Zhou, C.-H., Yan, J.-Y., Hu, B.-Y., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00659-4 · Cited by 369 · see citing works

Pancreatic cancer: why is it so hard to treat?

Oberstein, P. E., & Olive, K. P. (2013) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x13478680 · Cited by 334 · see citing works

Tumour microenvironment of pancreatic cancer: immune landscape is dictated by molecular and histopathological features

Karamitopoulou, E. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0479-5 · Cited by 298 · see citing works

Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma

Qian, Z. R., Rubinson, D. A., Nowak, J. A., Morales-Oyarvide, V., Dunne, R. F., Kozak, M. M., Welch, M. W., Brais, L. K., Da Silva, A., Li, T., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3420 · Cited by 260 · see citing works

Chronic stress accelerates pancreatic cancer growth and invasion: A critical role for beta-adrenergic signaling in the pancreatic microenvironment

Kim-Fuchs, C., Le, C. P., Pimentel, M. A., Shackleford, D., Ferrari, D., Angst, E., Hollande, F., & Sloan, E. K. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.02.019 · Cited by 287 · see citing works

Experimental microdissection enables functional harmonisation of pancreatic cancer subtypes

Maurer, C., Holmstrom, S. R., He, J., Laise, P., Su, T., Ahmed, A., Hibshoosh, H., Chabot, J. A., Oberstein, P. E., Sepulveda, A. R., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317706 · Cited by 216 · see citing works

Advanced-stage pancreatic cancer: therapy options

Werner, J., Combs, S. E., Springfeld, C., Hartwig, W., Hackert, T., & Büchler, M. W. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.66 · Cited by 217 · see citing works

Pancreatic Cancer Metabolism: Breaking It Down to Build It Back Up

Perera, R. M., & Bardeesy, N. M. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0671 · Cited by 213 · see citing works

The pancreatic cancer genome revisited

Hayashi, A., Hong, J., & Iacobuzio-Donahue, C. A. (2021) · Nature Reviews Gastroenterology &amp; Hepatology · doi:10.1038/s41575-021-00463-z · Cited by 211 · see citing works

A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinoma

Hayashi, A., Fan, J., Chen, R., Ho, Y.-J., Makohon-Moore, A. P., Lecomte, N., Zhong, Y., Hong, J., Huang, J., Sakamoto, H., et al. (2020) · Nature Cancer · doi:10.1038/s43018-019-0010-1 · Cited by 204 · see citing works

RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma

Whittle, M. C., Izeradjene, K., Rani, P. G., Feng, L., Carlson, M. A., DelGiorno, K. E., Wood, L. D., Goggins, M., Hruban, R. H., Chang, A. E., et al. (2015) · Cell · doi:10.1016/j.cell.2015.04.048 · Cited by 203 · see citing works

New therapeutic strategies to treat human cancers expressing mutant p53 proteins

Blandino, G., & Agostino, S. D. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0705-7 · Cited by 198 · see citing works

Organoid models of gastrointestinal cancers in basic and translational research

Lau, H. C.-H., Kranenburg, O., Xiao, H., & Yu, J. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0255-2 · Cited by 195 · see citing works

Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer

Takai, E., Totoki, Y., Nakamura, H., Morizane, C., Nara, S., Hama, N., Suzuki, M., Furukawa, E., Kato, M., Hayashi, H., et al. (2015) · Scientific Reports · doi:10.1038/srep18425 · Cited by 173 · see citing works

Evolution and dynamics of pancreatic cancer progression

Yachida, S., & Iacobuzio–Donahue, C. A. (2013) · Oncogene · doi:10.1038/onc.2013.29 · Cited by 185 · see citing works

New Treatment Strategies for Metastatic Pancreatic Ductal Adenocarcinoma

Singh, R., & O'Reilly, E. M. (2020) · Drugs · doi:10.1007/s40265-020-01304-0 · Cited by 156 · see citing works

Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement

Coriat, R., Walter, T., Terris, B., Couvelard, A., & Ruszniewski, P. B. (2016) · The Oncologist · doi:10.1634/theoncologist.2015-0476 · Cited by 151 · see citing works

Molecular subtypes in cancers of the gastrointestinal tract

Bijlsma, M. F., Sadanandam, A., Tan, P. B. O., & Vermeulen, L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.33 · Cited by 130 · see citing works

Therapeutic options for the management of pancreatic cancer

Rossi, M. L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i32.11142 · Cited by 127 · see citing works

Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells

Pelosi, E., Castelli, G., & Testa, U. (2017) · Biomedicines · doi:10.3390/biomedicines5040065 · Cited by 124 · see citing works

The Evolutionary Origins of Recurrent Pancreatic Cancer

Sakamoto, H., Attiyeh, M. A., Gerold, J. M., Makohon-Moore, A. P., Hayashi, A., Hong, J., Kappagantula, R. L., Zhang, L., Melchor, J. P., Reiter, J. G., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1508 · Cited by 118 · see citing works

Emerging roles for the IL-6 family of cytokines in pancreatic cancer

van Duijneveldt, G., Griffin, M. D. W., & Putoczki, T. L. (2020) · Clinical Science · doi:10.1042/cs20191211 · Cited by 118 · see citing works

Spatial mapping of transcriptomic plasticity in metastatic pancreatic cancer

Pei, G., Min, J., Rajapakshe, K., Branchi, V., Liu, Y., Selvanesan, B. C., Thege, F. I., Sadeghian, D., Zhang, D., Cho, K. S., et al. (2025) · Nature · doi:10.1038/s41586-025-08927-x · Cited by 114 · see citing works

Pancreatic undifferentiated carcinoma with osteoclast‐like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinoma

Luchini, C., Pea, A., Lionheart, G., Mafficini, A., Nottegar, A., Veronese, N., Chianchiano, P. E., Brosens, L. A. A., Noë, M., Offerhaus, G. J. A., et al. (2017) · The Journal of Pathology · doi:10.1002/path.4941 · Cited by 113 · see citing works

Molecular, morphological and survival analysis of 177 resected pancreatic ductal adenocarcinomas (PDACs): Identification of prognostic subtypes

Schlitter, A. M., Segler, A., Steiger, K., Michalski, C. W., Jäger, C., Konukiewitz, B., Pfarr, N., Endris, V., Bettstetter, M., Kong, B., et al. (2017) · Scientific Reports · doi:10.1038/srep41064 · Cited by 112 · see citing works

Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma

Wang, W.-Q., Liu, L., Xu, H.-X., Wu, C.-T., Xiang, J.-F., Xu, J., Liu, C., Long, J., Ni, Q.-X., & Yu, X. (2016) · British journal of surgery · doi:10.1002/bjs.10187 · Cited by 111 · see citing works

Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer

Giovannetti, E., van der Borden, C. L., Frampton, A. E., Ali, A., Firuzi, O., & Peters, G. J. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.04.006 · Cited by 108 · see citing works

Mutant p53: Multiple Mechanisms Define Biologic Activity in Cancer

Kim, M., Zhang, Y., & Lozano, G. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00249 · Cited by 108 · see citing works

Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer

Stefanoudakis, D., Frountzas, M., Schizas, D., Michalopoulos, N. V., Drakaki, A., & Toutouzas, K. G. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46040177 · Cited by 110 · see citing works

The hepatic pre-metastatic niche in pancreatic ductal adenocarcinoma

Houg, D. S., & Bijlsma, M. F. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0842-9 · Cited by 103 · see citing works

Very Long-term Survival Following Resection for Pancreatic Cancer Is Not Explained by Commonly Mutated Genes: Results of Whole-Exome Sequencing Analysis

Dal Molin, M., Zhang, M., de Wilde, R. F., Ottenhof, N. A., Rezaee, N., Wolfgang, C. L., Blackford, A., Vogelstein, B., Kinzler, K. W., Papadopoulos, N., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2600 · Cited by 101 · see citing works

Longitudinal monitoring of KRAS-mutated circulating tumor DNA enables the prediction of prognosis and therapeutic responses in patients with pancreatic cancer

Watanabe, F., Suzuki, K., Tamaki, S., Abe, I., Endo, Y., Takayama, Y., Ishikawa, H., Kakizawa, N., Saito, M., Futsuhara, K., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0227366 · Cited by 97 · see citing works

Somatic Mutations in Exocrine Pancreatic Tumors: Association with Patient Survival

Rachakonda, P. S., Bauer, A. S., Xie, H., Campa, D., Rizzato, C., Canzian, F., Beghelli, S., Greenhalf, W., Costello, E., Schanne, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060870 · Cited by 93 · see citing works

Development of bioluminescent chick chorioallantoic membrane (CAM) models for primary pancreatic cancer cells: a platform for drug testing

Rovithi, M. N., Avan, A., Funel, N., León, L. G., Gómez‐Mellado, V. E., Wurdinger, T. D., Griffioen, A. W., Verheul, H. M. W., & Giovannetti, E. (2017) · Scientific Reports · doi:10.1038/srep44686 · Cited by 93 · see citing works

Personalized pancreatic cancer therapy: from the perspective of mRNA vaccine

Huang, X., Zhang, G., Tang, T., Gao, X., & Liang, T. (2022) · Military Medical Research · doi:10.1186/s40779-022-00416-w · Cited by 95 · see citing works

GNASR201C Induces Pancreatic Cystic Neoplasms in Mice That Express Activated KRAS by Inhibiting YAP1 Signaling

Ideno, N., Yamaguchi, H., Ghosh, B., Gupta, S., Okumura, T., Steffen, D. J., Fisher, C. G., Wood, L. D., Singhi, A. D., Nakamura, M., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.08.006 · Cited by 80 · see citing works

Utility of Assessing the Number of Mutated KRAS, CDKN2A, TP53, and SMAD4 Genes Using a Targeted Deep Sequencing Assay as a Prognostic Biomarker for Pancreatic Cancer

Hayashi, H., Kohno, T., Ueno, H., Hiraoka, N., Kondo, S., Saito, M., Shimada, Y., Ichikawa, H., Kato, M., Shibata, T., et al. (2017) · Pancreas · doi:10.1097/mpa.0000000000000760 · Cited by 88 · see citing works

Key biological processes driving metastatic spread of pancreatic cancer as identified by multi-omics studies

Large, T. Y. S. L., Bijlsma, M. F., Geert Kazemier, M., van Laarhoven, H. W. M., Giovannetti, E., & Jiménez, C. R. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.03.008 · Cited by 88 · see citing works

Targeted Therapies for Pancreatic Cancer and Hurdles Ahead

Aslan, M., Shahbazi, R., Ulubayram, K., & Özpolat, B. (2018) · Anticancer Research · doi:10.21873/anticanres.13026 · Cited by 88 · see citing works

Comparison of endoscopic ultrasound tissue acquisition methods for genomic analysis of pancreatic cancer

Elhanafi, S. E., Mahmud, N., Vergara, N., Kochman, M. L., Das, K. K., Ginsberg, G. G., Rajala, M. W., & Chandrasekhara, V. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14540 · Cited by 87 · see citing works

Pathology of pancreatic ductal adenocarcinoma: Facts, challenges and future developments

Esposito, I. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i38.13833 · Cited by 87 · see citing works

Survival Among Patients With Pancreatic Cancer and Long-Standing or Recent-Onset Diabetes Mellitus

Yuan, C., Rubinson, D. A., Qian, Z. R., Wu, C. H., Kraft, P. L., Bao, Y., Ogino, S., Ng, K., Clancy, T. E., Swanson, R. S., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.5688 · Cited by 87 · see citing works

Emerging concepts in pancreatic cancer medicine: targeting the tumor stroma

Neeße, A., Gress, T. M., Tuveson, D. A., Michl, P., & Krug, S. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s38111 · Cited by 83 · see citing works

The conflicting roles of tumor stroma in pancreatic cancer and their contribution to the failure of clinical trials: a systematic review and critical appraisal

Bijlsma, M. F., & van Laarhoven, H. W. M. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-014-9541-1 · Cited by 84 · see citing works

Prognosis, Biology, and Targeting of TP53 Dysregulation in Multiple Myeloma

Flynt, E., Bisht, K. K., Sridharan, V., Ortiz, M., Towfic, F., & Thakurta, A. (2020) · Cells · doi:10.3390/cells9020287 · Cited by 76 · see citing works

Prediction of survival and recurrence in patients with pancreatic cancer by integrating multi-omics data

Baek, B., & Lee, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-76025-1 · Cited by 77 · see citing works

HNF1A is a novel oncogene that regulates human pancreatic cancer stem cell properties

Abel, E. V., Goto, M., Magnuson, B., Abraham, S. T., Ramanathan, N., Hotaling, E., Alaniz, A. A., Kumar‐Sinha, C., Dziubinski, M. L., Urs, S., et al. (2018) · eLife · doi:10.7554/elife.33947 · Cited by 73 · see citing works

Metarrestin, a perinucleolar compartment inhibitor, effectively suppresses metastasis

Frankowski, K. J., Wang, C., Patnaik, S., Schoenen, F. J., Southall, N. T., Li, D., Teper, Y., Sun, W., Kandela, I. K., Hu, D., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aap8307 · Cited by 72 · see citing works

Small extracellular vesicles: from mediating cancer cell metastasis to therapeutic value in pancreatic cancer

Zhang, W., Xing, J., Liu, T., Zhang, J., Dai, Z., Zhang, H., Wang, D., & Tang, D. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-021-00806-y · Cited by 71 · see citing works

Cuproptosis-related gene index: A predictor for pancreatic cancer prognosis, immunotherapy efficacy, and chemosensitivity

Huang, X., Zhou, S., Liu, Y., Tóth, J., & András, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.978865 · Cited by 68 · see citing works

High G2M Pathway Score Pancreatic Cancer is Associated with Worse Survival, Particularly after Margin-Positive (R1 or R2) Resection

Oshi, M., Newman, S., Tokumaru, Y., Yan, L., Matsuyama, R., Endo, I., Katz, M. H. G., & Takabe, K. (2020) · Cancers · doi:10.3390/cancers12102871 · Cited by 63 · see citing works

Neoplasms of the Exocrine Pancreas

Wolff, R. A., Crane, C. H., Li, D., Evans, D. B., Maitra, A., & Tsai, S. (2017) · Wiley eBooks · doi:10.1002/9781119000822.hfcm094 · Cited by 64 · see citing works

Analysis of the tumor-initiating and metastatic capacity of PDX1-positive cells from the adult pancreas

Ischenko, I., Petrenko, O., & Hayman, M. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319911111 · Cited by 62 · see citing works

Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells

Lee, J., Snyder, E. R., Liu, Y., Gu, X., Wang, J., Flowers, B. M., Kim, Y. J., Park, S., Szot, G. L., Hruban, R. H., et al. (2017) · Nature Communications · doi:10.1038/ncomms14686 · Cited by 62 · see citing works

Liquid biopsy in pancreatic cancer: the beginning of a new era

Yadav, D. K., Bai, X., Yadav, R. K., Singh, A., Li, G., Ma, T., Chen, W., & Liang, T. (2018) · Oncotarget · doi:10.18632/oncotarget.24809 · Cited by 60 · see citing works

Clinical Significance of GNAS Mutation in Intraductal Papillary Mucinous Neoplasm of the Pancreas With Concomitant Pancreatic Ductal Adenocarcinoma

Ideno, N., Ohtsuka, T., Matsunaga, T., Kimura, H., Watanabe, Y., Tamura, K., Aso, T., Aishima, S., Miyasaka, Y., Ohuchida, K., et al. (2014) · Pancreas · doi:10.1097/mpa.0000000000000258 · Cited by 60 · see citing works

Transcriptomic Analysis Predicts Survival and Sensitivity to Anticancer Drugs of Patients with a Pancreatic Adenocarcinoma

Duconseil, P., Gilabert, M., Gayet, O., Loncle, C., Moutardier, V., Turrini, O., Calvo, E. L., Ewald, J., Giovannini, M. F., Gasmi, M., et al. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.11.029 · Cited by 56 · see citing works

Reliable Detection of Somatic Mutations in Fine Needle Aspirates of Pancreatic Cancer With Next-generation Sequencing

Valero, V., Saunders, T., He, J. P., Weiss, M. J., Cameron, J. L., Dholakia, A. S., Wild, A. T., Shin, E. J., Khashab, M. A., Lennon, A. M., et al. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000001156 · Cited by 54 · see citing works

Pre-clinical Models of Metastasis in Pancreatic Cancer

Miquel, M., Zhang, S., & Pilarsky, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.748631 · Cited by 53 · see citing works

Discovery of New Targets to Control Metastasis in Pancreatic Cancer by Single-cell Transcriptomics Analysis of Circulating Tumor Cells

Markov, S. D., Perales-Patón, J., Bockorny, B., Dopazo, A., Muñoz, M., Baños, N., Bonilla, V., Menéndez, C., Durán, Y., Huang, L., et al. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-1166 · Cited by 50 · see citing works

Mutant p53 Together with TGFβ Signaling Influence Organ-Specific Hematogenous Colonization Patterns of Pancreatic Cancer

Zhong, Y., Macgregor‐Das, A. M., Saunders, T., Whittle, M. C., Makohon-Moore, A. P., Kohutek, Z. A., Poling, J., Herbst, B. T., Javier, B. M., Cope, L., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1615 · Cited by 48 · see citing works

Diagnosis of pancreatic lesions collected by endoscopic ultrasound-guided fine-needle aspiration using next-generation sequencing

Kameta, E., Sugimori, K., Kaneko, T., Ishii, T., Miwa, H., Sato, T. A., Ishii, Y., Sue, S., Sasaki, T., Yamashita, Y., et al. (2016) · Oncology Letters · doi:10.3892/ol.2016.5168 · Cited by 47 · see citing works

Focal adhesion kinase inhibition synergizes with nab-paclitaxel to target pancreatic ductal adenocarcinoma

Large, T. Y. S. L., Bijlsma, M. F., Hassouni, B. E., Mantini, G., Lagerweij, T., Henneman, A. A., Funel, N., Kok, B., Pham, T. V., Haas, R. D. G.-D., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01892-z · Cited by 44 · see citing works

The dynamic interactions between the stroma, pancreatic stellate cells and pancreatic tumor development: Novel therapeutic targets

Farran, B., & Nagaraju, G. P. (2019) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2019.07.001 · Cited by 46 · see citing works

Functional p38 MAPK Identified by Biomarker Profiling of Pancreatic Cancer Restrains Growth through JNK Inhibition and Correlates with Improved Survival

Zhong, Y., Naito, Y., Cope, L., Naranjo‐Suarez, S., Saunders, T., Hong, S., Goggins, M., Herman, J. M., Wolfgang, C. L., & Iacobuzio–Donahue, C. A. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2823 · Cited by 44 · see citing works

A MEK/PI3K/HDAC inhibitor combination therapy for KRAS mutant pancreatic cancer cells

Ischenko, I., Petrenko, O., & Hayman, M. J. (2015) · Oncotarget · doi:10.18632/oncotarget.4538 · Cited by 42 · see citing works

Oncolytic Virus-Mediated Targeting of the ERK Signaling Pathway Inhibits Invasive Propensity in Human Pancreatic Cancer

Koujima, T., Tazawa, H., Ieda, T., Araki, H., Fushimi, T., Shoji, R., Kuroda, S., Kikuchi, S., Yoshida, R., Umeda, Y., et al. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.03.016 · Cited by 43 · see citing works

Novel strategies using modern radiotherapy to improve pancreatic cancer outcomes: toward a new standard?

Bouchart, C., Navez, J., Closset, J., Hendlisz, A., Gestel, D. V., Moretti, L., & Laethem, J. V. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920936093 · Cited by 43 · see citing works

Advanced Pancreatic Ductal Adenocarcinoma: Moving Forward

Franck, C., Müller, C., Rosania, R., Croner, R. S., Pech, M., & Venerito, M. (2020) · Cancers · doi:10.3390/cancers12071955 · Cited by 41 · see citing works

The novel driver gene ASAP2 is a potential druggable target in pancreatic cancer

Fujii, A., Masuda, T., Iwata, M., Tobo, T., Wakiyama, H., Koike, K., Kosai, K., Nakano, T., Kuramitsu, S., Kitagawa, A., et al. (2021) · Cancer Science · doi:10.1111/cas.14858 · Cited by 42 · see citing works

Autophagy, p53, and Pancreatic Cancer

Iacobuzio–Donahue, C. A., & Herman, J. M. (2014) · New England Journal of Medicine · doi:10.1056/nejmcibr1400189 · Cited by 41 · see citing works

Genomic characterization of patient-derived xenograft models established from fine needle aspirate biopsies of a primary pancreatic ductal adenocarcinoma and from patient-matched metastatic sites

Allaway, R. J., Fischer, D. A., Abreu, F. B. D., Gardner, T. B., Gordon, S. R., Barth, R. J., Colacchio, T. A., Wood, M. D., Kacsoh, B. Z., Bouley, S. J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7718 · Cited by 41 · see citing works

Valproic acid exhibits anti-tumor activity selectively against EGFR/ErbB2/ErbB3-coexpressing pancreatic cancer via induction of ErbB family members-targeting microRNAs

Lin, T., Ren, Q., Zuo, W., Jia, R., Xie, L., Lin, R., Zhao, H., Chen, J., Yan, L., Wang, P., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1160-9 · Cited by 40 · see citing works

Tbx3 fosters pancreatic cancer growth by increased angiogenesis and activin/nodal-dependent induction of stemness

Perkhofer, L., Walter, K., Costa, I. G., Carrasco, M. C. R., Eiseler, T., Hafner, S., Genze, F., Zenke, M., Bergmann, W., Illing, A., et al. (2016) · Stem Cell Research · doi:10.1016/j.scr.2016.08.007 · Cited by 39 · see citing works

Prognostic stratification of resected pancreatic ductal adenocarcinoma: Past, present, and future

Barhli, A., Cros, J. F., Bartholin, L., & Neuzillet, C. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.08.009 · Cited by 38 · see citing works

Genomic Heterogeneity of Pancreatic Ductal Adenocarcinoma and Its Clinical Impact

Gutiérrez, M. L., Muñoz‐Bellvís, L., & Órfão, A. (2021) · Cancers · doi:10.3390/cancers13174451 · Cited by 38 · see citing works

Evolving pancreatic cancer treatment: From diagnosis to healthcare management

Milella, M., Bassi, C., Boggi, U., Brunetti, O., Cavaliere, A., Crippa, S., Vita, F. D., Falconi, M., Frassineti, G. L., Giommoni, E., et al. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103571 · Cited by 37 · see citing works

Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma

Tanaka, T., Masuda, A., Inoue, J., Hamada, T., Ikegawa, T., Toyama, H., Sofue, K., Shiomi, H., Sakai, A., Kobayashi, T., et al. (2023) · Journal of Gastroenterology · doi:10.1007/s00535-022-01939-8 · Cited by 36 · see citing works

Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis

Luckett, T., Abudula, M., Ireland, L., Glenn, M. A., Bellomo, G., Stafferton, R., Halloran, C. M., Ghaneh, P., Jones, R. P., Schmid, M. C., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-1542 · Cited by 37 · see citing works

Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease

Murphy, S. J., Hart, S. N., Halling, G. C., Johnson, S. H., Smadbeck, J. B., Drucker, T., Lima, J. F., Rohakhtar, F. R., Harris, F. R., Kosari, F., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-2198 · Cited by 37 · see citing works

Fibroblasts in the Aged Pancreas Drive Pancreatic Cancer Progression

Zabransky, D. J., Chhabra, Y., Fane, M. E., Kartalia, E., Leatherman, J. M., Hüser, L., Zimmerman, J. W., Delitto, D., Han, S., Armstrong, T. D., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-0086 · Cited by 36 · see citing works

Pentose conversions support the tumorigenesis of pancreatic cancer distant metastases

Bechard, M. E., Word, A. E., Tran, A. V., Liu, X., Locasale, J. W., & McDonald, O. G. (2018) · Oncogene · doi:10.1038/s41388-018-0346-5 · Cited by 35 · see citing works

High‐Load Gemcitabine Inorganic–Organic Hybrid Nanoparticles as an Image‐Guided Tumor‐Selective Drug‐Delivery System to Treat Pancreatic Cancer

Ischyropoulou, M., Sabljo, K., Schneider, L., Niemeyer, C. M., Napp, J., Feldmann, C., & Alves, F. (2023) · Advanced Materials · doi:10.1002/adma.202305151 · Cited by 35 · see citing works

Recent advances in precision medicine for pancreatic ductal adenocarcinoma

Hayashi, H., Higashi, T., Miyata, T., Yamashita, Y., & Baba, H. (2021) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12436 · Cited by 34 · see citing works

Early diagnosis of pancreatic cancer: Current trends and concerns

Hanada, K., Amano, H., & Abe, T. (2017) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12004 · Cited by 33 · see citing works

Metachronous intraductal papillary mucinous neoplasms disseminate via the pancreatic duct following resection

Nagai, K., Mizukami, Y., Omori, Y., Kin, T., Yane, K., Takahashi, K., Ono, Y., Sugitani, A., Karasaki, H., Shinohara, T., et al. (2019) · Modern Pathology · doi:10.1038/s41379-019-0405-7 · Cited by 33 · see citing works

Klassifikation und malignes Potenzial der zystischen Pankreastumoren

Esposito, I., Schlitter, A. M., Sipos, B., & Klöppel, G. (2014) · Der Pathologe · doi:10.1007/s00292-014-1971-6 · Cited by 29 · see citing works

Radiofrequency ablation for locally advanced pancreatic cancer: SMAD4 analysis segregates a responsive subgroup of patients

Paiella, S., Malleo, G., Cataldo, I., Gasparini, C., Pastena, M. D., Marchi, G. D., Marchegiani, G., Rusev, B. C., Scarpa, A., Girelli, R., et al. (2017) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-017-1627-0 · Cited by 29 · see citing works

Integration of Bioinformatics Resources Reveals the Therapeutic Benefits of Gemcitabine and Cell Cycle Intervention in SMAD4-Deleted Pancreatic Ductal Adenocarcinoma

Hsieh, Y., Liu, T., Chou, C.-J., Chen, H., Lee, K., & Yang, P. (2019) · Genes · doi:10.3390/genes10100766 · Cited by 28 · see citing works

An Oncogenic ALK Fusion and an RRAS Mutation in KRAS Mutation-Negative Pancreatic Ductal Adenocarcinoma

Shimada, Y., Kohno, T., Ueno, H., Ino, Y., Hayashi, H., Nakaoku, T., Sakamoto, Y., Kondo, S., Morizane, C., Shimada, K., et al. (2017) · The Oncologist · doi:10.1634/theoncologist.2016-0194 · Cited by 28 · see citing works

Genomic Variations in Pancreatic Cancer and Potential Opportunities for Development of New Approaches for Diagnosis and Treatment

Lu, S., Ahmed, T., Du, P., & Wang, Y. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061201 · Cited by 26 · see citing works

Identification of genomic alterations and associated transcriptomic profiling reveal the prognostic significance of MMP14 and PKM2 in patients with pancreatic cancer

Wang, H., Wang, X., Xu, L., Lin, Y., Zhang, J., & Cao, H. (2020) · Aging · doi:10.18632/aging.103958 · Cited by 26 · see citing works

Thrombospondin-1 overexpression stimulates loss of Smad4 and accelerates malignant behavior via TGF-β signal activation in pancreatic ductal adenocarcinoma

Matsumura, K., Hayashi, H., Uemura, N., Ogata, Y., Liu, Z., Sato, H., Shiraishi, Y., Kuroki, H., Kitamura, F., Kaida, T., et al. (2022) · Translational Oncology · doi:10.1016/j.tranon.2022.101533 · Cited by 25 · see citing works

The ‘SPARC’ of life: Analysis of the role of osteonectin/SPARC in pancreatic cancer (Review)

ROSSI, M. K., Gnanamony, M., & Gondi, C. S. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3417 · Cited by 25 · see citing works

Response of germline BRCA2-mutated advanced pancreatic acinar cell carcinoma to olaparib

Mao, L., Mou, Y., Hou, S., Cao, D., & Li, A. (2018) · Medicine · doi:10.1097/md.0000000000013113 · Cited by 25 · see citing works

KRAS, CDKN2A, TP53, And SMAD4 Alterations in Relation to Postoperative Survival and Recurrence Patterns Among Patients with Pancreatic CancerPreprint

Masugi, Y., Takamatsu, M., Tanaka, M. H., Hara, K., Inoue, Y., Hamada, T., Suzuki, T., Arita, J., Hirose, Y., Kawaguchi, Y., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4197932

Post-operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and SMAD4 expression

Yohei, M., Manabu, T., Mariko, T., Kensuke, H., Yosuke, I., Tsuyoshi, H., Tatsunori, S., Jun’ichi, A., Yuki, H., Kawaguchi, Y., et al. (2023) · Institutional Repositories DataBase (IRDB)

Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma

Qian, Z. R., Rubinson, D. A., Nowak, J. A., Morales-Oyarvide, V., Dunne, R. F., Kozak, M. M., Welch, M. W., Brais, L. K., Da Silva, A., Li, T., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3420 · Cited by 260 · see citing works

Scientists Link Pancreatic Cancer Survival to Four Genes

(2017) · Oncology Times · doi:10.1097/01.cot.0000527378.05900.e0

Clinical Effect of Driver Mutations of <i>KRAS, CDKN2A/P16, TP53</i> , and <i>SMAD4</i> in Pancreatic Cancer: A Meta-Analysis

Gu, Y., Ji, Y., Jiang, H., & Qiu, G. (2020) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2020.0078 · Cited by 28 · see citing works